Towards novel therapeutics for HIV through fragment-based screening and drug design-Reference-Cited by-同舟云学术

Towards novel therapeutics for HIV through fragment-based screening and drug design

Published:2014-11 Issue:2-3 Volume:116 Page:124-140
ISSN:0079-6107
Container-title:Progress in Biophysics and Molecular Biology
language:en
Short-container-title:Progress in Biophysics and Molecular Biology

Author:

Tiefenbrunn Theresa,Stout C. David

Funder

National Institutes of Health, National Institute for General Medical Sciences

Molecular Basis of Viral Pathogenesis Training

Publisher

Elsevier BV

Subject

Molecular Biology,Biophysics

Reference41 articles.

1. Allosteric inhibitor development targeting HIV-1 integrase;Al-Mawsawi;ChemMedChem,2011

2. Molecular basis for drug resistance in HIV-1 protease;Ali;Viruses,2011

3. Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design;Bauman;Nucleic Acids Res.,2008

4. Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening;Bauman;J. Med. Chem.,2013

5. Fragment-based Lead discovery and optimization using X-Ray crystallography, computational chemistry, and high-throughput organic synthesis;Blaney,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Fragment-Based Drug Discovery in Tuberculosis and HIV;Pharmaceuticals;2022-11-15

2. Virtual article collection on infectious diseases;Progress in Biophysics and Molecular Biology;2022-07

3. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 4-[4-Arylpyridin-1(4H)-yl]benzoic Acid Derivatives as Anti-HIV-1 Agents;Chemistry & Biodiversity;2017-12

4. Improving combination antiretroviral therapy by targeting HIV-1 gene transcription;Expert Opinion on Therapeutic Targets;2016-06-18

5. Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends;Journal of Medicinal Chemistry;2015-11-05